Oragenics Files 8-K: Material Agreement, Other Events
Ticker: OGEN · Form: 8-K · Filed: Sep 5, 2024 · CIK: 1174940
| Field | Detail |
|---|---|
| Company | Oragenics INC (OGEN) |
| Form Type | 8-K |
| Filed Date | Sep 5, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001, $0.55, $0.549, $125,000, $4.45 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, 8-k
Related Tickers: ORGN
TL;DR
ORGN entered a material definitive agreement, filed 8-K on Sept 4.
AI Summary
On September 4, 2024, Oragenics, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial statements/exhibits. The company is incorporated in Florida and its principal executive offices are located in Sarasota.
Why It Matters
This 8-K filing indicates Oragenics, Inc. has entered into a significant agreement, which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's stock price.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- September 4, 2024 (date) — Date of Report
- Florida (location) — State of Incorporation
- Sarasota (location) — Principal Executive Offices City
FAQ
What is the nature of the material definitive agreement Oragenics, Inc. entered into?
The filing does not specify the details of the material definitive agreement, only that one was entered into on or before September 4, 2024.
What other items are included in this 8-K filing besides the material agreement?
The filing also includes information on 'Other Events' and 'Financial Statements and Exhibits'.
When was Oragenics, Inc. incorporated?
Oragenics, Inc. was incorporated in Florida.
What is Oragenics, Inc.'s principal executive office address?
The principal executive offices are located at 1990 Main Street, Suite 750, Sarasota, FL 34236.
What is the SIC code for Oragenics, Inc.?
The Standard Industrial Classification (SIC) code for Oragenics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 1,137 words · 5 min read · ~4 pages · Grade level 11 · Accepted 2024-09-05 16:45:12
Key Financial Figures
- $0.001 — 4 shares of its common stock, par value $0.001 per share ("Common Stock"), or pre-fund
- $0.55 — f the parties. The Offering Price was $0.55 per shares of Common Stock. The Pre-Fun
- $0.549 — nts were priced at an offering price of $0.549 per Pre-Funded Warrant, which is equal
- $125,000 — le fees of legal counsel, not to exceed $125,000. In addition, the Company agreed to iss
- $4.45 million — roceeds to the Company of approximately $4.45 million before deducting placement agent fees a
- $3.79 million — o use the net proceeds of approximately $3.79 million from the offering to fund the continued
Filing Documents
- form8-k.htm (8-K) — 58KB
- ex1-1.htm (EX-1.1) — 216KB
- ex4-1.htm (EX-4.1) — 127KB
- ex4-2.htm (EX-4.2) — 125KB
- ex4-3.htm (EX-4.3) — 120KB
- ex10-1.htm (EX-10.1) — 288KB
- ex99-1.htm (EX-99.1) — 13KB
- ex99-2.htm (EX-99.2) — 10KB
- 0001493152-24-035166.txt ( ) — 1320KB
- ogen-20240904.xsd (EX-101.SCH) — 3KB
- ogen-20240904_lab.xml (EX-101.LAB) — 33KB
- ogen-20240904_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 5 th day of September, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer